ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HZD Horizon Discovery Group Plc

184.50
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Horizon Discovery Group Plc LSE:HZD London Ordinary Share GB00BK8FL363 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 184.50 184.50 185.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Horizon Discovery Group plc Result of AGM (6477C)

18/06/2019 1:16pm

UK Regulatory


Horizon Discovery (LSE:HZD)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Horizon Discovery Charts.

TIDMHZD

RNS Number : 6477C

Horizon Discovery Group plc

18 June 2019

Horizon Discovery Group plc

Result of AGM

Cambridge, UK, 18 June 2019: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or "the Company"), a global leader in the application of gene editing and gene modulation technologies, announces that at its Annual General Meeting held today at 12.00 p.m. at the Company's offices, all resolutions were duly passed.

Ends

For further information from Horizon Discovery Group plc, please contact:

Horizon Discovery Group plc

Terry Pizzie, Chief Executive Officer

Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Tel: +44 (0) 1223 655 580

Numis Securities Limited (Broker and NOMAD)

James Black / Freddie Barnfield / Duncan Monteith

Tel: +44 (0) 207 260 1000

Consilium Strategic Communications (Financial Media and Investor Relations)

Mary-Jane Elliott / Matthew Neal / Melissa Gardiner

Tel: +44 (0) 20 3709 5700

Email: horizon@consilium-comms.com

About Horizon Discovery Group plc www.horizondiscovery.com

Horizon Discovery Group plc (LSE: HZD) ("Horizon") is a world leader in gene editing and gene modulation tools and their use. We have more than 10 years' experience of building cell models and our unmatched toolset and expertise enable our customers to answer key questions across research, drug discovery, drug development and diagnostics.

Horizon's platforms and capabilities enable researchers to alter almost any gene or modulate its function in human or mammalian cell-lines. Our customers include many of the world's leading academic institutes and global pharmaceutical companies. Our expertise and insights into the challenges that they face, is driving us to create innovative products and services that not only differentiate our business, but also help our customers to achieve deeper understanding of biological systems, thereby fuelling the development of the next wave of precision medicine.

Horizon is headquartered in Cambridge, UK with offices in USA and Japan. The Group is listed on the London Stock Exchange's AIM market under the ticker HZD.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGCKFDDBBKDNAD

(END) Dow Jones Newswires

June 18, 2019 08:16 ET (12:16 GMT)

1 Year Horizon Discovery Chart

1 Year Horizon Discovery Chart

1 Month Horizon Discovery Chart

1 Month Horizon Discovery Chart

Your Recent History

Delayed Upgrade Clock